Hospital Care Collaboration and Licensing Deals 2016-2023

$3,995.00

Hospital Care Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2023

Publication date
October 2023
Number of pages
350+
Product type
Therapy profile
Available formats
PDF document
Report edition
4
SKU
CP2220

Hospital Care Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the hospital care deals entered into by the worlds leading biopharma companies.

Fully revised and updated, the report provides details of hospital care deals from 2016 to 2023.

The report provides access to deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred – contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of collaboration and licensing deals announced since 2016 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual licensing contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of hospital care dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an analysis of the trends in hospital care dealmaking.

Chapter 3 covers the financial deal terms for deals signed in the hospital care field with stage of development announced. Deals are listed and sectioned by headline value, upfront payment, milestone payment and royalty rates.

Chapter 4 provides a review of the top 25 most active biopharma companies in hospital care dealmaking. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

Chapter 5 provides a comprehensive and detailed review of hospital care deals signed and announced since 2016 where a contract document is available. Each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of hospital care deals listed by theraeutic target.

The report also includes numerous table and figures that illustrate the trends and activities in hospital care deal making since 2016.

In addition, a comprehensive deal directory is provided organized by company A-Z and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

 

Key benefits

Hospital Care Collaboration and Licensing Deals provides the reader with the following key benefits:

  • Understand deal trends since 2016
  • Browse hospital care collaboration and licensing deals
  • Benchmark analysis – identify market value of transactions
  • Financials terms - upfront, milestone, royalties
  • Directory of deals by company A-Z, therapy focus and technology type
  • Leading deals by value
  • Most active dealmakers
  • Identify assets and deal terms for each transaction
  • Access contract documents - insights into deal structures
  • Due diligence - assess suitability of your proposed deal terms for partner companies
  • Save hundreds of hours of research time

 

Report scope

Hospital Care Collaboration and Licensing Deals is intended to provide the reader with an in-depth understanding of hospital care trends and structure of deals entered into by leading biopharma companies worldwide.

Hospital Care Collaboration and Licensing Deals includes:

  • Trends in hospital care dealmaking in the biopharma industry
  • Overview of collaboration and licensing deal structure
  • Directory of hospital care deal records covering pharmaceutical and biotechnology
  • The leading hospital care deals by value
  • Most active hospital care licensing dealmakers

In Hospital Care Collaboration and Licensing Deals, the available deals are listed by:

  • Company A-Z
  • Headline value
  • Therapeutic area
  • Technology type

Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where available.

Hospital Care Collaboration and Licensing Deals provides comprehensive access to available records for deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

  • What are the precise rights granted or optioned?
  • What is actually granted by the agreement to the partner company?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How are sales and payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are IPRs handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes to be resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law?

Hospital Care Collaboration and Licensing Deals provides the reader with the following key benefits:

  • Understand deal trends since 2016
  • Browse hospital care collaboration and licensing deals
  • Benchmark analysis – identify market value of transactions
  • Financials terms - upfront, milestone, royalties
  • Directory of deals by company A-Z, therapy focus and technology type
  • Leading deals by value
  • Most active dealmakers
  • Identify assets and deal terms for each transaction
  • Access contract documents - insights into deal structures
  • Due diligence - assess suitability of your proposed deal terms for partner companies
  • Save hundreds of hours of research time

Executive Summary

 

Chapter 1 – Introduction

 

Chapter 2 – Trends in hospital care dealmaking

 

2.1. Introduction

2.2. Hospital care partnering over the years     

2.3. Hospital care partnering by deal type

2.4. Hospital care partnering by industry sector

2.5. Hospital care partnering by stage of development

2.6. Hospital care partnering by technology type

2.7. Hospital care partnering by therapeutic indication

 

Chapter 3 – Financial deal terms for hospital care partnering

 

3.1. Introduction

3.2. Disclosed financials terms for hospital care partnering

3.3. Hospital care partnering headline values

3.4. Hospital care deal upfront payments

3.5. Hospital care deal milestone payments

3.6. Hospital care royalty rates

 

Chapter 4 – Leading hospital care deals and dealmakers

 

4.1. Introduction

4.2. Most active in hospital care partnering

4.3. List of most active dealmakers in hospital care    

4.4. Top hospital care deals by value

 

Chapter 5 – Hospital care contract document directory

                                            

5.1. Introduction

5.2. Hospital care partnering deals where contract document available

 

Chapter 6 – Hospital care dealmaking by therapeutic target

 

6.1. Introduction

6.2. Deals by hospital care therapeutic target

 

Deal directory

 

Deal directory – Hospital care deals by company A-Z 2016 to 2023

Deal directory – Hospital care deals by technology type 2016 to 2023

 

Deal type definitions

 

About Wildwood Ventures

 

Current Partnering

Current Agreements

Recent report titles from CurrentPartnering

 

Table of figures

 

Figure 1: Hospital care partnering since 2016

Figure 2: Hospital care partnering by deal type since 2016

Figure 3: Hospital care partnering by industry sector since 2016

Figure 4: Hospital care partnering by stage of development since 2016

Figure 5: Hospital care partnering by technology type since 2016

Figure 6: Hospital care partnering by indication since 2016

Figure 7: Hospital care deals with a headline value

Figure 8: Hospital care deals with upfront payment values

Figure 9: Hospital care deals with milestone payment

Figure 10: Hospital care deals with royalty rates

Figure 11: Active hospital care dealmaking activity since 2016

Figure 12: Top hospital care deals by value since 2016

Pricing options

  • $3,995: single-user (encrypted file - one user/device)
  • $5,995: multi-user (encrypted file - up to 5 users/devices)
  • $9,995: company (unencrypted file)

Single and Multi-user license files are encrypted PDF documents. Details of how to access using Javelin3 PDF Reader will be provided at report delivery.

Company license files are not encrypted and can be accessed using a PDF Reader.

A full explanation of license type definitions can be found here.

 

Our guarantee

 

Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.

 

Delivery Deadline

We guarantee that the report will be sent within the specified delivery times. In the unlikely case of a delay we may offer a partial refund as compensation. (Terms may apply)

 

Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.

 

Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

All card payments are processed by Evalon.

 

Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.

 

Total Trust

Current Partnering is part of Wildwood Ventures Ltd., based in York, United Kingdom. We have been trading successfully online since 2009 and work with some of the most famous brands in the business. We carefully select our partners to ensure that the publications meet expectations of demanding customers.

3D-Side, 3D Systems, 3M, 7 Hills Pharma, 7D Surgical, 34 Lives, 111, Absolute Antibody, Acacia Research, Accenture, Accuray, Acelrx Pharmaceuticals, Acentrus Specialty, Acerus, ActLight, AdaptivEndo, ADAS 3D Medical, Advanz Pharma, AdventHealth, Aethlon Medical, AgeX Therapeutics, AgNovos Healthcare, Aguettant, AIBody, Aidoc, Aiforia Technologies, Aitrics, Albert Einstein College of Medicine, Alfasigma, Aligned Orthopedic Partners, AliveCor, ALK-Abello, Allay Therapeutics, Allegheny Technologies, Allergan, Allergan Aesthetics, Alloksys Life Sciences, AlloSource, Alnylam Pharmaceuticals, Alpha Tau Medical, Alume Biosciences, Alyzen Medical Physics, Amag Pharmaceuticals, Ambra Health, AMC Health, Amedica, Amend Surgical, American Academy of Orthopaedic Surgeons, American College of Chest Physicians, American Health Imaging, Amgen, Amicrobe, Amplyx Pharmaceuticals, Ancestry, Angion Biomedica, Angsana Molecular & Diagnostics, Antares Pharma, Anthem, Antibe Therapeutics, Apex Physics Partners, Apogee Biotechnology, Apple, argenx, Argon Medical Devices, Aridis Pharmaceuticals, Armis Biopharma, Arthrex, Asahi Kasei, Asensus Surgical, AskAt, Astellas Pharma, AstraZeneca, Athersys, Attune Medical, Augusta University Health, Auris Health, Australian Biotechnologies, Autonomous Healthcare, Avalon SteriTech, Avania, Avanos Medical, Avita Therapeutics, AVRA Surgical, Avrobio, Axial3D, Axis Lighting, B-Line Medical, BAMF Health, Battelle, Baxter International, B Braun, BC Platforms, Be-ys, Becton Dickinson, BeiGene, Belfor, Ben-Gurion University, Be The Match BioTherapies, Biedermann Motech, Bimini Health Tech, Bio-Techne, Biofourmis, BioHybrid Solutions, BioIntelliSense, Biomedical Advanced Research and Development Authority, Biomet, Biomodex, BioPep, Bioplate, BioQ Pharma, Bioservo Technologies, BioT Medical, Biotricity, Biovo Technologies, Bird Foundation, Blackrock Neurotech, Blinktbi, Blood Centers of America, Blue Cedar, Bluejay Diagnostics, Blueprint Genetics, Blue Water Resolute Innovations, Blum Center for Health, Boa Technology, Bolder BioTechnology, Bone Biologics, BoneSmart, Bone Solutions, BoneSupport, Bone Therapeutics, Boryung Pharmaceutical, Boston Scientific, BoyaLife, BrainLAB, Brain Treatment Center San Diego, Breath of Life International, Brigham and Women's Hospital, Brooks Rehabilitation, BT BeaMedical Technologies, BTL Industries, Butterfly Network, Cadila Pharmaceuticals, Calyptus Pharmaceuticals, Canntab Therapeutics, Canon Medical Informatics, Capricor Therapeutics, CARB-X, CardioNXT, CardioSert, CARE, CareDox, CareDx, CarePoint Health, Carestream Health, Caresyntax, Carrum Health, Casetabs, CB2 Insights, Cellastra, Cellect Biotechnology, Celling Biosciences, CELLINK, Cellthera Pharma, Center for Health Affairs, Center for International Blood and Marrow Transplant Research, Cerhum, Cerner, Cerus, CgBio, CheckedUp, CHF Solutions, Chiesi Farmaceutici, Children's Hospital Boston, Children's Hospital Los Angeles, Children's Hospital of Michigan Foundation, Children's Hospital of Philadelphia, Children's Minnesota, China Grand Pharmaceutical, ChoiceSpine, Christiana Care Health System, Christus Health, Chronolife, Cidara Therapeutics, Cigna Healthcare, Cipher Skin, Cirle, Cirrus Dx, CirrusMD, Citius Pharmaceuticals, ClearPoint Neuro, Clerkenwell Health, Cleveland Clinic, CLEW Medical, Clinerion, Clinical Laserthermia Systems (CLS), CMDC Labs, Coalition for the Advancement of Research and Innovation in Trauma, CoapTech, Collplant, Columbia University, Concordia University, Concord Medical Services Holdings, ConforMIS, Cook Biotech, Copenhagen University Hospital, Coracoid Solutions, Corindus Vascular Robotics, Cornell University, CraniUS, Crescita Therapeutics, Cricket Health, CSL, CSL Plasma, Cumberland Pharmaceuticals, Curexo, CurveBeam AI, Cystic Fibrosis Foundation, CytoSorbents, D&K Engineering, Dalhousie University, Daxor, Dealmed Medical Supplies, Debiopharm, Defense Advanced Research Projects Agency, Defense Threat Reduction Agency, Definition Health, Demcon, Department of Defence, Department of Defense, DePuy, DermapenWorld, Devyser Diagnostics, DiA Imaging Analysis, Diaspective Vision, Dicom Systems, Dignitana, DILIsym Services, Disior, Diversified, Dr. Agarwal’s Eye Hospitals, Duke University, Durect, Dutch SAZ, Dynasil, Eagle Pharmaceuticals, Eastman Kodak, EBM-Solutions, EBSCO Information Services, eCential Robotics, eClinicalHealth, eGenesis, Egis, EHang Holdings, Ehave, Eirion Therapeutics, Eko, Eledon Pharmaceuticals, Elemaster Group, Elemental Machines, Elevai Labs, Eligo Bioscience, Eli Lilly, Elute, Embolx, Emergency Medicine Foundation, Emphysys, Enalare Therapeutics, Endoluxe, EndoQuest Robotics, Enzychem Lifesciences, Epimune Diagnostics, Ergomed, ETH Zurich, Etiometry, Eureka Eurostars, Eurobio, Eurofins Scientific, Eurofins Viracor, Euroimmun, European Commission, European Society for Organ Transplantation, European Union, European Union Regional Development Fund, European Wellness Biomedical Group, Everest Medicines, EvidNet, Evonik Industries, Exactech, ExCellThera, Exo, ExOne Company, Exosome Diagnostics, EyePoint Pharmaceuticals, F4 Pharma, Feinstein Institute for Medical Research, Ferrum Health, Field, Field Medical, Filament Health, Fitabase, FitBit, Flexion Therapeutics, Flexpoint Sensor Systems, Food and Drug Administration (FDA), Fosun Pharmaceutical, Foundation Medicine, Franklin Innovation, Fresenius Medical Care, FUJIFILM SonoSite, Galderma, Gamida Cell, Ganymed Robotics, GE Healthcare, GEn1E Lifesciences, Genome Medical, George Clinical, Georgia Institute of Technology, Georgian Bay General Hospital, German Heart Centre Berlin, Gestalt Diagnostics, Getinge, Gigagen, Global Kinetics, Global Orthopaedic Technology, Glytec, G Medical Innovations, Google, Government of Israel, GPCR Therapeutics, Greatbatch, Great Belief International, Grifols, Group K Diagnostics, Grunenthal, Guangdong Provincial People's Hospital, Guys and St Thomas NHS Foundation Trust, Hadassah Medical Center, HAI Solutions, Hamad Medical, Hamilton Health Sciences, Hansa Biopharma, Hanuman Pelican, Harmonic Bionics, Harrow Health, Harvard Medical School, Harvard University, Hatch Medical, HCA Healthcare, Healeon Medical, Healios K.K., Health Care Originals, HealthEast, Health Network Laboratories, HealthPort, HealthTrio, Heidelberg Pharma, Helsinn Healthcare, Helsinn Therapeutics, Hemogenyx, Henry Ford Health System, Henry Schein, Highmark Health, Himed, HistoWiz, Hoboken University Medical Center and Christ Hospital, HoliStick Medical, Horizon Europe, Hospital for Special Surgery, Houston Methodist Research Institute, HP, HSTpathways, HTDK Group, Humacyte, HydroCision, Hyperfine Research, Ibex Medical Analytics, IBM Watson Health, Icahn School of Medicine at Mount Sinai, ICM, iCRYO Cryotherapy, IDbyDNA, IGEA Clinical Biophysics, iGeneTRAiN, IM-Tech, ImageBiopsy Lab, ImmersiveTouch, Immucor, Immugenyx, ImplantBase, Implant Surfaces, Impressio, Imricor Medical Systems, In-Office Pathology, INanoBio, Indiana University, Induce Biologics, iNGENu, Innocoll, Innovasource, Innovative Cellular Therapeutics, Inotrem, Inovytec, Insel Gruppe, Inserm Transfert, InSightec, InsightRX, Inspirata, Institute for Bioscience and Biotechnology Research, Integrated Computer Solutions, Intel, Intellego Technologies, IntelliTek Health, Interface People, International Society for Heart and Lung Transplantation, International Society of Heart and Lung Transplantation, International Spine Study Group Foundation, InTouch Health, Intuitive Surgical, IntuitiveX, Invenio Imaging, Invibio Biomaterial Solutions, Invotek Group, iotaMotion, Irras, iSchemaView, Jan Medical, Janssen Biotech, Janssen Pharmaceuticals, Japan Agency for Medical Research and Development, Jasper Therapeutics, Jazz Pharmaceuticals, Jellagen, Jhpiego, Jiangsu NHWA Pharmaceutical, Johns Hopkins Medicine (JHM), Johns Hopkins University, Johnson & Johnson, Johnson & Johnson Innovation, Jordan-Young Institute, JustRight Surgical, Juyou Biotechnology, K2M, Kaleido Biosciences, Kamada, Kane Biotech, Kangaroo Health, Kanomax USA, Karius, Karolinska University Hospital, Kelyniam Global, Kentucky Organ Donor Affiliates, Kerma Medical Products, Kern Medical, Kindeva Drug Delivery, Kinetic Concepts, Kings College London, Kinova, KiOmed Pharma, Kit Check, Klaria, Komodo Health, Kyocera, Lattice Semiconductor, Lazurite, Leica Biosystems, LG Life Sciences, Life Image, Lightbeam Health Solutions, Lima Corporate, Linus Biotechnology, Lirio, Liverpool School of Tropical Medicine, Locate Bio, Loma Linda University, Long Grove Pharmaceuticals, Loopback Analytics, Loop Insights, Los Altos Pharmaceuticals, Lung Biotechnology, Lung Transplant Foundation, Lunit, Maastricht University, MaaT Pharma, Macao Kiang Wu Hospital, Magenta Therapeutics, Magic Leap, Main Line Health, Maitri Health Technologies, Mallinckrodt Pharmaceuticals, Manhattan Scientifics, Martindale Pharma, Masimo, Massachusetts General Hospital, Massachusetts Institute of Technology, MassRobotics, Materialise, Mauna Kea Technologies, Maxx Medical, Mayo Clinic, MBio Diagnostics, McMaster University, MD Anderson Cancer Center, MD Matrix, Meabco, Medac, Medacta, Medexus Pharmaceuticals, MediBioSense, Medical iSight, Medical Microinstruments, Medical Product Laboratories, Medical Technology Enterprise Consortium, Medical Tracking Solutions, MediciNova, MediPines, Medison Pharma, Medistics, Medizone International, Medpod, MedReleaf, MedShape, Medtronic, Meiji Seika, Mellon Medical, Memorial Sloan Kettering Cancer Center, Mentice, Mentor, Mercury Bio, Merit Medical Systems, Mesoblast, MiCare Path, Michelson Diagnostic, Microbot Medical, Microsoft, MiMedx, MIM Software, Ministry of Defence, Miromatrix Medical, Misonix, Mitacs, MJH Life Sciences, Moberg Pharma, Molecular Templates, Monteris Medical, Montreal Heart Institute, Moray Medical, MORE Health, Mount Sinai Health System, Movendo Technology, MRI Interventions, mSKIL, Mundipharma, Musculoskeletal Transplant Foundation, MyndVR, MYOS, myTomorrows, Nano-X Imaging, Nantes University, NantHealth, NASA, Natera, National Cancer Institute, National Center for Advancing Translational Sciences (NCATS), National Healthcare Services (NHS), National Health Service, National Heart, Lung and Blood Institute, National Institute for Environmental Health Sciences, National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal Diseases, National Institute of Neurological Disorders and Stroke, National Institute on Drug Abuse (NIDA), National Institutes of Health, National Science Foundation, Natural Sciences and  Engineering Research Council of Canada, Nautilus, Naval Medical Research Center, Naver, Navigate Surgical Technologies, NavLab, NDR Medical Technology, NDS Surgical Imaging, NeoImmuneTech, Neo Medical, Neovii Pharmaceuticals, NE Scientific, Neurocare Group, NeuroLogica, NeuroproteXeon, NeuroVasc, NeuroVive Pharmaceutical, Neutron Therapeutics, Nevakar, New York Blood Center, Ninety One, Nippon Shinyaku, Norgine, North American Pediatric Renal Trials and Collaborative Studies, Northwell Health, Northwestern Medicine Developmental Therapeutics Institute, Northwestern University, Novanta, Novant Health, Novartis, Novaseek Research, Novozymes, NTT Data, NTT Medical Center Tokyo, Nu-med Plus, Nuance Pharma, Numerate, Nunzi Pharmaceutical, Nuo Therapeutics, NuVasive, NuvOx Pharma, Nvidia, nView Medical, NYU Grossman School of Medicine for Preclinical and Clinical Research, NYU Langone Medical Center, NZ Technologies, Ochsner Health System, Ocumension Therapeutics, Ology Bioservices, Omeros, Omixon, Omnicell, Omnilife Science, OmniVision Technologies, OMRF, Omron, OncoImmune, One Lambda, Oneome, OneOncology, Onkos Surgical, Ontario Clinical Oncology Group, Ophirex, Opiant Pharmaceuticals, Optimus Integrated Surgical Environment, OptraSCAN, Opus Medical, OrganX, Orgenesis, Orthocell, Orthofix Medical, OrthoGrid Systems, Orthopaedic Research and Education Foundation, OrthoRebirth, Ortho Regenerative Technologies, OrthoSensor, Ortoma, OSE Immunotherapeutics, Ossium Health, Osteopore International, Ovation Pharmaceuticals, oVio Technologies, Owkin, Owlstone Medical, Pacira Biosciences, Paige, Paracelsus Clinics, Paragonix Technologies, Paragon Medical, Partner Therapeutics, Parvizi Surgical Innovation, Pathan, PathogenX, PathSensors, PatientBond, PatientFi, Pennsylvania State University, PeriGen, Pfizer, Phantom Neuro, Pharmanest, PharmaTher, PharMEDium, PhaseBio Pharmaceuticals, Philips, PhysIQ, Pilloxa, Pirche, Planmeca, Planmed, Platelet BioGenesis, Pleuratech, Plexus, Pluri, Pluristem Therapeutics, Poietis, Polyganics, PolyPid, Poseida Therapeutics, Pramana, Preceyes, PrecisionOS, Premier Health Group, Premier Inc, Prevacus, ProAssurance, Procept BioRobotics, Progenerative Medical, Promedica International, Prometheus Laboratories, Promimic, Promore Pharma, Proniras, Proprio, Proscia, ProtoKinetix, Provepharm, Proximie, Psyence Group, Psyence Therapeutics, Pulmocide, Pulmodyne, Purdue Pharma, Qihan Biotech, QMed Innovations, Quadrant Biosciences, Quest Diagnostics, Raziel Therapeutics, RCSI University of Medicine and Health Sciences, ReadCoor, Real Time Medical, Recovery Force, RecoveryOne, RedHill Biopharma, Redox, Reliq Health, RenalytixAI, Replicel Life Sciences, RespiraWorks, restor3d, ReSuture, Revance Therapeutics, Revive Therapeutics, Rex Medical, RH Nanopharmacuticals, Rigshospitalet, Riverain Medical, RMX Biopharma, Roche Diagnostics, Rothman Healthcare, Rothman Orthopaedic Institute, Rotterdam Eye Hospital, Royal Philips Electronics, RTI Surgical, S12 Solutions, Salient Surgical Technologies, Samsung Electronics, Sana Klinikum Offenbach, Sandoz, Sarah Cannon Research Institute, SATT Lutech, Schreiner Group, Scientific Analytics, Sciton, SeaSpine, SeaStar Medical, Sectra, Sedor Pharmaceuticals, Select Rehabilitation, SeLux Diagnostics, Sema4, Serenus.AI, Seres Therapeutics, Serum Institute of India, Shanghai Haohai Biological Technology, Shanghai RAAS Blood Products, Shenzhen Radiusen Systems, Shimadzu, Shina Systems, Shionogi, Siemens Healthineers, Sientra, Signum Surgical, Simulations Plus, Sinclair Pharmaceuticals, Sinovant Sciences, Sintetica, Sirona Biochem, SIRS Therapeutics, SiteOne Therapeutics, Sites Medical, Small Business Innovation Research, Smith & Nephew, Society of NeuroInterventional Surgery, Society of Vascular and Interventional Neurology, SoftBank Robotics Group, Sofwave Medical, Soliton, Sonata Scientific, SonoSpine, Southwest Research Institute, Spacelabs Healthcare, Spectrum Spine, SpineThera, Spire Health, SQI Diagnostics, SRI International, St. Catherine Specialty Hospital, Stanford University, Starzl Network for Excellence in Pediatric Transplantation, Stereotaxis, SteriLumen, Stevenson Memorial Hospital, St George Street Capital, Stimit, Stratasys, Stryker, Summit Orthopedics, Suneva Medical, SUNY Upstate Medical University, Surge Cardiovascular, Surgical Affiliates, Surgical Care Affiliates (SCA), Surgical Notes, Surgical Theater, SurgiGyn, Swedish Bactiguard, Syapse, Syneos Health, Synopsis Healthcare, Taiba, TaiGen Biotechnology, Talaris Therapeutics, Talis Biomedical, TBG Management, Technical University of Denmark (DTU), Teijin, Teleflex, Telix Pharmaceuticals, TELUS Ventures, Temple Health, Terasaki Innovation Center, Terso Solutions, Terumo Blood and Cell Technologies, Terumo Cardiovascular Systems, Tetra Bio-Pharma, Teva Pharmaceutical Industries, TFF Pharmaceuticals, The International AIDS Vaccine Initiative, The Joint Pathology Center, Theracell, Theradaptive, Thermo Fisher Scientific, Theromics, The Technical University Of Munich, The University of Chicago Medicine, THINK Surgical, Thomas Jefferson University, Tianjin JuveStar Biotech, Titan Medical, Tivic Health Systems, Tokyo Medical and Dental University, Tomahawk Charitable Solutions, TONIX Pharmaceuticals, Total Joint Orthopedics, Toyoda Gosei, Transcriptome Sciences, TransEnterix, Transimmune, Transplant Genomics, Tribun Health, Trillium Therapeutics, TriNetX, Turner Imaging Systems, Turn Therapeutics, TxCell, Tyber Medical, Tyto Care, UCB, UMass Memorial Medical Center, uMotif, Unimedic, United Imaging Healthcare, United Orthopedic Group, United Therapeutics, UniteOR, University Health Network, University Hospitals Ventures, University Libre of Brussels, University Medical Center Utrecht, University of British Columbia, University of California San Francisco, University of Central Florida Research Foundation, University of Erlangen, University of Florida Research Foundation, University of Louisville, University of Maryland, University of Maryland Baltimore, University of Maryland School of Medicine, University of Maryland Ventures, University of Memphis, University of Minnesota, University of Nebraska, University of Oxford, University of Pittsburgh, University of Texas, University of Tokyo, University of Washington, University of Wisconsin-Madison, Uppsalagruppen Medical, UpToDate, US Air Force, USARAD, US Army, US Army Institute of Surgical Research (USAISR), US Army Medical Research and Material Command, US Army Medical Research Institute of Chemical Defense, US Government, US Navy, US Radiology Specialists, Vaica Medical, VeeMed, Velico Medical, Velos, Veloxis Pharmaceuticals, VenatoRx, Venus Medtech, Veracyte, Vera Therapeutics, Verb Surgical, Vericel, Verity Pharmaceuticals, Versant Diagnostics, Vertex Pharmaceuticals, Veta Health, Vexos, ViaClean Technologies, Vicarious Surgical, Vifor Pharma, ViraCor Laboratories, VirtaMed, Visiopharm, VisualDx, Vitaeris, VitaHEAT Medical, Vital Connect, VitalHub, VitalTech, Vithas Group, Vitro Biopharma, Vitruvias Therapeutics, Vivacelle Bio, Vivus, Voicebrook, VUNO, Vuzix, Wake Forest Institute for Regenerative Medicine, Walloon Region Investment Fund, Wego Group, Weill Cornell Medical College, Wellcome Trust, Windgap Medical, Winhealth Pharma Group, WishBone Medical, WiTricity, W L Gore, Wyss Institute, Xcede Technologies, xCures, Xenon Pharmaceuticals, Ximedica, XRHealth, Xtant Medical, Xvivo Perfusion, Xylyx Bio, Yale School of Medicine, YOFOTO (China) Health Industry, YouRehab, Zebra Medical Vision, Zephyr AI, Zeta Surgical, Zimmer Biomet, Zyter

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• CRADA
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.